Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

Dairy, soy, and risk of breast cancer: those confounded milks https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyaa007/5743492#199259276 Dairy, soy, and risk of breast cancer: those confounded milks Gary E Fraser, Karen Jaceldo-Siegl, Michael Orlich, Andrew Mashchak, Rawiwan Sirirat, Synnove Knutsen International […]

In 2008 the results of a small study were published reporting on the use of choline stabilized orthosilicic acid a form of silicon, or placebo in 184 women with low […]

On January 18, 2023, INOVAIT and the Government of Canada announced a major investment in the field of image-guided therapy (IGT).

Each year, Alberta Health Services (the province wide, fully-integrated health system in Alberta) recognizes exceptional accomplishments by teams across the province through the President’s Excellence Awards.  Alberta’s Fracture Liaison Service […]

Osteoporosis Canada’s Quality Standards for Fracture Liaison Services in Canada were developed to support implementation of effective FLS. They provide clear guidance for healthcare professionals and administrators on what an effective FLS […]

Fracture Liaison Service (FLS) FLS: MAKE YOUR FIRST BREAK YOUR LAST! A Fracture Liaison Service (FLS) is a specific model of care where a coordinator pro-actively identifies fracture patients, on […]

Healthcare Provider Webinar: Biologics & Biosimilars – An Overview for Healthcare Providers In the treatment of osteoporosis, biologic and biosimilar medications may be provided as part of a treatment plan. […]

A Fracture Liaison Service (FLS) is a specific model of care where a coordinator pro-actively identifies fracture patients, on a system-wide basis, and determines their fracture risk with the express […]